TY - JOUR
T1 - Update of prognosis and characteristics of chronic obstructive pulmonary disease in a real-world setting
T2 - a 5-year follow-up analysis of a multi-institutional registry
AU - Takano, Tomotsugu
AU - Tsubouchi, Kazuya
AU - Hamada, Naoki
AU - Ichiki, Katsuyuki
AU - Torii, Ryo
AU - Takata, Shohei
AU - Kawakami, Satoru
AU - Nakagaki, Noriaki
AU - Yoshida, Makoto
AU - Kitasato, Yasuhiko
AU - Tobino, Kazunori
AU - Harada, Eiji
AU - Ishii, Hiroshi
AU - Wataya, Hiroshi
AU - Maeyama, Takashige
AU - Fujita, Masaki
AU - Yatera, Kazuhiro
AU - Okamoto, Masaki
AU - Yabuuchi, Hidetake
AU - Kiyomi, Fumiaki
AU - Tokunaga, Shoji
AU - Nakanishi, Yoichi
AU - Okamoto, Isamu
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Background: We conducted a prospective observational study to elucidate the long-term prognosis and management of chronic obstructive pulmonary disease (COPD) in clinical practice in Japan in the mid-2010s. Methods: This prospective cohort study included 29 facilities. Data from 427 patients clinically diagnosed with COPD, enrolled between September 2013 and April 2016, were analyzed. Interstitial pneumonia was excluded through a central multidisciplinary discussion. Follow-up data were collected for up to 5 years after patient registration. Results: At the time of registration, 53 patients clinically diagnosed with COPD did not have airflow limitation (AFL). In the cohort with AFL (n = 374), 232 patients completed a 5-year follow-up, while 49 patients died during the 1576.6 person-years of observation. The mean age was 71.7 years with an overall 5-year survival rate of 85.4%. Stratified by % forced expiratory volume in one second (FEV1), survival rates were 93.6% in the mild and moderate AFL group, 82.5% in the severe AFL group, and 66.1% in the very severe AFL group. The prognosis of the subpopulation without AFL was poor with a 5-year survival of 81.6%. This subpopulation exhibited respiratory symptoms, low vital capacity and total lung capacity, and emphysematous changes. Conclusions: Our study presents the 5-year survival and real-world clinical practice scenario of a prospective cohort of patients clinically diagnosed with COPD in Japan in the mid-2010s. The survival rates of our cohort were numerically better than the Japanese cohort in the 1990s, regardless of the high median age of this cohort. Overall, 12.4% of the patients in this cohort with no AFL at registration exhibited respiratory symptoms and distinct spirometric patterns, and had a poor prognosis.
AB - Background: We conducted a prospective observational study to elucidate the long-term prognosis and management of chronic obstructive pulmonary disease (COPD) in clinical practice in Japan in the mid-2010s. Methods: This prospective cohort study included 29 facilities. Data from 427 patients clinically diagnosed with COPD, enrolled between September 2013 and April 2016, were analyzed. Interstitial pneumonia was excluded through a central multidisciplinary discussion. Follow-up data were collected for up to 5 years after patient registration. Results: At the time of registration, 53 patients clinically diagnosed with COPD did not have airflow limitation (AFL). In the cohort with AFL (n = 374), 232 patients completed a 5-year follow-up, while 49 patients died during the 1576.6 person-years of observation. The mean age was 71.7 years with an overall 5-year survival rate of 85.4%. Stratified by % forced expiratory volume in one second (FEV1), survival rates were 93.6% in the mild and moderate AFL group, 82.5% in the severe AFL group, and 66.1% in the very severe AFL group. The prognosis of the subpopulation without AFL was poor with a 5-year survival of 81.6%. This subpopulation exhibited respiratory symptoms, low vital capacity and total lung capacity, and emphysematous changes. Conclusions: Our study presents the 5-year survival and real-world clinical practice scenario of a prospective cohort of patients clinically diagnosed with COPD in Japan in the mid-2010s. The survival rates of our cohort were numerically better than the Japanese cohort in the 1990s, regardless of the high median age of this cohort. Overall, 12.4% of the patients in this cohort with no AFL at registration exhibited respiratory symptoms and distinct spirometric patterns, and had a poor prognosis.
KW - 5-year survival rate
KW - COPD
KW - Normal spirometry
KW - Real-world registry
UR - http://www.scopus.com/inward/record.url?scp=85208689282&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85208689282&partnerID=8YFLogxK
U2 - 10.1186/s12890-024-03347-5
DO - 10.1186/s12890-024-03347-5
M3 - Article
C2 - 39506773
AN - SCOPUS:85208689282
SN - 1471-2466
VL - 24
JO - BMC Pulmonary Medicine
JF - BMC Pulmonary Medicine
IS - 1
M1 - 556
ER -